amiodarone has been researched along with Arteriosclerosis, Coronary in 25 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sotalol is a commonly prescribed antiarrhythmic drug (AAD) used for maintaining sinus rhythm in patients with atrial fibrillation (AF)." | 9.19 | Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. ( Al-Khatib, SM; Allen-LaPointe, N; Anstrom, KJ; Daubert, JP; DeWald, T; Horton, JR; Lokhnygina, Y; Peterson, ED; Piccini, JP; Shaw, LK; Steinberg, BA; Thomas, K; Wojdyla, DM, 2014) |
| "We studied the use of perioperative IV and oral administration of amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (CABG)." | 9.11 | Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. ( Hollander, G; Kerstein, J; Lichstein, E; Majid, M; Qamar, M; Shani, J; Soodan, A, 2004) |
| "Amiodarone is one of the most efficient and safe antiarrhythmic drugs in the treatment of atrial fibrillation (AF)." | 7.73 | "Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis. ( Bitzen, A; Lewalter, T; Lüderitz, B; Schrickel, JW; Schwab, JO; Yang, A, 2006) |
| "Although amiodarone appears to have few pro-arrhythmic effects, torsade de pointes (TdP) has been observed during long-term drug administration, usually in conjunction with electrolyte disturbances, a change in drug dosage, or concomitant drug therapy." | 7.73 | Torsade de pointes induced by short-term oral amiodarone therapy. ( Ahn, JC; Kim, YH; Lim, HE; Pak, HN; Song, WH, 2006) |
| "No sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, or cardiovascular mortality were observed." | 5.72 | Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation. ( Aksu, T; Aras, D; Cay, S; Kara, M; Ozcan, F; Ozeke, O; Topaloglu, S, 2022) |
| "Sotalol is a commonly prescribed antiarrhythmic drug (AAD) used for maintaining sinus rhythm in patients with atrial fibrillation (AF)." | 5.19 | Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. ( Al-Khatib, SM; Allen-LaPointe, N; Anstrom, KJ; Daubert, JP; DeWald, T; Horton, JR; Lokhnygina, Y; Peterson, ED; Piccini, JP; Shaw, LK; Steinberg, BA; Thomas, K; Wojdyla, DM, 2014) |
| "We studied the use of perioperative IV and oral administration of amiodarone for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass graft surgery (CABG)." | 5.11 | Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study. ( Hollander, G; Kerstein, J; Lichstein, E; Majid, M; Qamar, M; Shani, J; Soodan, A, 2004) |
| "We enrolled all consecutive patients with unsuccessful/not feasible catheter ablation and ineffective/contraindicated amiodarone or beta-blockers, which started the mexiletine treatment for refractory ventricular tachycardia (VT) or ventricular fibrillation (VF) between January 2010 and January 2020." | 4.12 | Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study. ( Bilato, C; Cavedon, S; Mecenero, A; Mugnai, G; Paolini, C; Perrone, C, 2022) |
| "We evaluated the hypothesis that a relationship exists between inflammation and the outcome of pharmaceutical cardioversion with amiodarone in recent onset atrial fibrillation." | 3.74 | Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome. ( Dragomanovits, S; Kalogeropoulos, AS; Kremastinos, DT; Papathanasiou, S; Rigopoulos, AG; Rizos, I; Sakadakis, EA; Tsiodras, S, 2007) |
| "Amiodarone is one of the most efficient and safe antiarrhythmic drugs in the treatment of atrial fibrillation (AF)." | 3.73 | "Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis. ( Bitzen, A; Lewalter, T; Lüderitz, B; Schrickel, JW; Schwab, JO; Yang, A, 2006) |
| "Although amiodarone appears to have few pro-arrhythmic effects, torsade de pointes (TdP) has been observed during long-term drug administration, usually in conjunction with electrolyte disturbances, a change in drug dosage, or concomitant drug therapy." | 3.73 | Torsade de pointes induced by short-term oral amiodarone therapy. ( Ahn, JC; Kim, YH; Lim, HE; Pak, HN; Song, WH, 2006) |
| "Amiodarone is a class III antiarrhythmic drug containing 37% iodine by weight, with a structure similar to that of thyroid hormones." | 2.72 | Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders. ( Burman, KD; Wartofsky, L; Ylli, D, 2021) |
| "No sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, or cardiovascular mortality were observed." | 1.72 | Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation. ( Aksu, T; Aras, D; Cay, S; Kara, M; Ozcan, F; Ozeke, O; Topaloglu, S, 2022) |
| "Polymorphic ventricular tachycardia (VT) without QT prolongation is well described in patients without structural heart disease (mainly idiopathic ventricular fibrillation and Brugada syndrome) and in patients with acute ST-elevation myocardial infarction." | 1.51 | Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease. ( Amit, G; Asher, E; Belhassen, B; Chorin, E; Halkin, A; Havakuk, O; Hochstadt, A; Laish-Farkash, A; Lee, JK; Rosso, R; Tovia-Brodie, O; Viskin, D; Viskin, S, 2019) |
| "Amiodarone is a widely used and very potent antiarrhythmic substance." | 1.39 | Amiodarone-induced pulmonary toxicity--a fatal case report and literature review. ( Breithardt, G; Buerke, B; Hilker, E; Lebiedz, P; Range, FT, 2013) |
| "Bidirectional ventricular tachycardia (BVT) is an uncommon type of polymorphic ventricular tachycardia (PVT) with alternating polarity of the QRS complex most commonly described digitalis toxicity." | 1.38 | Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation. ( Bhavnani, SP; Clyne, CA, 2012) |
| "As the population ages, recurrent ventricular tachycardia (VT) is increasingly encountered in elderly patients with ischemic heart disease." | 1.36 | Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease. ( Inada, K; Koplan, BA; Roberts-Thomson, KC; Seiler, J; Steven, D; Stevenson, WG; Tedrow, UB, 2010) |
| "Amiodarone is a very effective antiarrhytmic drug." | 1.34 | Hyperglobulinemia in amiodarone-induced pneumonitis. ( Antipov, N; Farfel, Z; Mayan, H; Mouallem, M; Sela, BA, 2007) |
| "Amiodarone tissue uptake was quantified by high-performance liquid chromatography, and xanthine oxidase-dependent superoxide anion formation was investigated in vitro in presence or absence of amiodarone." | 1.34 | Antioxidant activity and sex differences of acute vascular effects of amiodarone in advanced atherosclerosis. ( Barton, M; Bhattacharya, I; Fojtu, E; Ha, HR; Jochum, W; Keller, M; Lang, M; Mundy, AL; Traupe, T, 2007) |
| "Amiodarone or sotalol was used in all postoperative patients for 6 months, except in 8 who had bradycardia." | 1.33 | Ablation of atrial fibrillation using microwave energy--early experience. ( Hamzeh, K; Jamil, H; Kabbani, SS; Murad, G; Sabbagh, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 10 (40.00) | 29.6817 |
| 2010's | 10 (40.00) | 24.3611 |
| 2020's | 3 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cay, S | 1 |
| Kara, M | 1 |
| Ozcan, F | 1 |
| Ozeke, O | 1 |
| Aksu, T | 1 |
| Aras, D | 1 |
| Topaloglu, S | 1 |
| Ylli, D | 1 |
| Wartofsky, L | 1 |
| Burman, KD | 1 |
| Mugnai, G | 1 |
| Paolini, C | 1 |
| Cavedon, S | 1 |
| Mecenero, A | 1 |
| Perrone, C | 1 |
| Bilato, C | 1 |
| Elnaggar, MN | 1 |
| Jbeili, K | 1 |
| Nik-Hussin, N | 1 |
| Kozhippally, M | 1 |
| Pappachan, JM | 1 |
| Viskin, S | 1 |
| Chorin, E | 1 |
| Viskin, D | 1 |
| Hochstadt, A | 1 |
| Halkin, A | 1 |
| Tovia-Brodie, O | 1 |
| Lee, JK | 1 |
| Asher, E | 1 |
| Laish-Farkash, A | 1 |
| Amit, G | 1 |
| Havakuk, O | 1 |
| Belhassen, B | 1 |
| Rosso, R | 1 |
| Plechev, VV | 1 |
| Zagidullin, ShZ | 1 |
| Iunusov, VM | 1 |
| Zubareva, IG | 1 |
| Nikolaeva, IE | 1 |
| Passaloglou, IT | 1 |
| Sabashnikov, A | 1 |
| Zeriouh, M | 1 |
| Reutter, S | 1 |
| Fatullayev, J | 1 |
| Choi, YH | 1 |
| Wahlers, T | 1 |
| Piccini, JP | 1 |
| Al-Khatib, SM | 1 |
| Wojdyla, DM | 1 |
| Shaw, LK | 1 |
| Horton, JR | 1 |
| Lokhnygina, Y | 1 |
| Anstrom, KJ | 1 |
| DeWald, T | 1 |
| Allen-LaPointe, N | 1 |
| Steinberg, BA | 1 |
| Thomas, K | 1 |
| Daubert, JP | 1 |
| Peterson, ED | 1 |
| Nouri, SN | 1 |
| Block, BL | 1 |
| Zebis, LR | 1 |
| Christensen, TD | 1 |
| Thomsen, HF | 1 |
| Hjortdal, VE | 1 |
| Inada, K | 1 |
| Roberts-Thomson, KC | 1 |
| Seiler, J | 1 |
| Steven, D | 1 |
| Tedrow, UB | 1 |
| Koplan, BA | 1 |
| Stevenson, WG | 1 |
| Bhavnani, SP | 1 |
| Clyne, CA | 1 |
| Farooq, V | 1 |
| Serruys, PW | 1 |
| Bourantas, C | 1 |
| Vranckx, P | 1 |
| Diletti, R | 1 |
| Garcia Garcia, HM | 1 |
| Holmes, DR | 1 |
| Kappetein, AP | 1 |
| Mack, M | 1 |
| Feldman, T | 1 |
| Morice, MC | 1 |
| Colombo, A | 1 |
| Morel, MA | 1 |
| de Vries, T | 1 |
| van Es, GA | 1 |
| Steyerberg, EW | 1 |
| Dawkins, KD | 1 |
| Mohr, FW | 1 |
| James, S | 1 |
| Ståhle, E | 1 |
| Range, FT | 1 |
| Hilker, E | 1 |
| Breithardt, G | 1 |
| Buerke, B | 1 |
| Lebiedz, P | 1 |
| Kerstein, J | 1 |
| Soodan, A | 1 |
| Qamar, M | 1 |
| Majid, M | 1 |
| Lichstein, E | 1 |
| Hollander, G | 1 |
| Shani, J | 1 |
| Kabbani, SS | 1 |
| Murad, G | 1 |
| Jamil, H | 1 |
| Sabbagh, A | 1 |
| Hamzeh, K | 1 |
| Schrickel, JW | 1 |
| Schwab, JO | 1 |
| Yang, A | 1 |
| Bitzen, A | 1 |
| Lüderitz, B | 1 |
| Lewalter, T | 1 |
| Lim, HE | 1 |
| Pak, HN | 1 |
| Ahn, JC | 1 |
| Song, WH | 1 |
| Kim, YH | 1 |
| Minhaj, MM | 1 |
| Zvara, DA | 1 |
| Nayyar, P | 1 |
| Maslow, A | 1 |
| Mouallem, M | 1 |
| Antipov, N | 1 |
| Mayan, H | 1 |
| Sela, BA | 1 |
| Farfel, Z | 1 |
| Rizos, I | 1 |
| Tsiodras, S | 1 |
| Rigopoulos, AG | 1 |
| Dragomanovits, S | 1 |
| Kalogeropoulos, AS | 1 |
| Papathanasiou, S | 1 |
| Sakadakis, EA | 1 |
| Kremastinos, DT | 1 |
| Traupe, T | 1 |
| Keller, M | 1 |
| Fojtu, E | 1 |
| Bhattacharya, I | 1 |
| Lang, M | 1 |
| Ha, HR | 1 |
| Jochum, W | 1 |
| Mundy, AL | 1 |
| Barton, M | 1 |
| Nägele, H | 1 |
| Behrens, S | 1 |
| Castel, A | 1 |
| Tanttula, K | 1 |
| Pappinen, H | 1 |
| Hämäläinen, P | 1 |
| Lupanov, VP | 1 |
| Sidorenko, BA | 1 |
| Nekrutman, EA | 1 |
| Kulikova, TV | 1 |
| Podinovskaia, IaA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival[NCT03417050] | 2,636 participants (Actual) | Observational | 2016-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for amiodarone and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders.
Topics: Albania; Amiodarone; Arrhythmias, Cardiac; Coronary Artery Disease; Humans; Male; Middle Aged; Myoca | 2021 |
Amiodarone-Induced Thyroid Dysfunction: A Clinical Update.
Topics: Amiodarone; Anti-Arrhythmia Agents; Chest Pain; Coronary Artery Disease; Humans; Male; Middle Aged; | 2018 |
4 trials available for amiodarone and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cause of Death; Coronary Artery Disea | 2014 |
Amiodarone protects diabetics and non-diabetics undergoing coronary artery bypass grafting equally.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Coronary Arte | 2008 |
Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.
Topics: Aged; Amiodarone; Coronary Artery Bypass; Coronary Artery Disease; Female; Gastrointestinal Hemorrha | 2012 |
Giving IV and oral amiodarone perioperatively for the prevention of postoperative atrial fibrillation in patients undergoing coronary artery bypass surgery: the GAP study.
Topics: Administration, Oral; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Case-Control St | 2004 |
19 other studies available for amiodarone and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Propafenone use in coronary artery disease patients undergoing atrial fibrillation ablation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Disease; Death, Sudden, Car | 2022 |
Mexiletine for ventricular arrhythmias in patients with chronic coronary syndrome: a cohort study.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Coronary Artery Disease | 2022 |
Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Drug Evaluation; Drug Resistance; | 2019 |
[Prophylactic use of VFS in patients with coronary artery disease in the perioperative coronary artery bypass grafting].
Topics: Aconitine; Amiodarone; Anti-Arrhythmia Agents; Chemoprevention; Comparative Effectiveness Research; | 2013 |
Rapid diagnostics and treatment of early complications after CABG surgery: a life saver.
Topics: Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Coronary Artery Disease; | 2013 |
Triple Oral Antithrombotic Therapy: A Teachable Moment.
Topics: Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Chest Pain; Coronary Artery Disease; Drug-Elu | 2016 |
Mortality and safety of catheter ablation for antiarrhythmic drug-refractory ventricular tachycardia in elderly patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Amiodarone; Anti-Arrhythmia Agents; Body Surface Pot | 2010 |
Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Defibrillators, Implantable; Drug-Eluti | 2012 |
Amiodarone-induced pulmonary toxicity--a fatal case report and literature review.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Drug Overdose; Fatal Outcome; Hal | 2013 |
Ablation of atrial fibrillation using microwave energy--early experience.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Catheter Ablation; Coronary Ar | 2005 |
"Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Arter | 2006 |
Torsade de pointes induced by short-term oral amiodarone therapy.
Topics: Administration, Oral; Adult; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillat | 2006 |
Case 1-2007 morbidly obese patient undergoing cardiac surgery.
Topics: Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterizatio | 2007 |
Hyperglobulinemia in amiodarone-induced pneumonitis.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Female; Humans | 2007 |
Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; C-Reactive Protein | 2007 |
Antioxidant activity and sex differences of acute vascular effects of amiodarone in advanced atherosclerosis.
Topics: Acetylcholine; Amiodarone; Animals; Antioxidants; Aorta; Apolipoproteins E; Coronary Artery Disease; | 2007 |
Ventricular tachycardia and aggravation of Brugada ECG pattern in a patient with coronary artery disease and combined amiodarone and betablocker therapy.
Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Coronary Ar | 2008 |
[Pain attacks causing muscle cramps].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Defibrillators, Implantable; Elec | 1999 |
[Experience with 5 years of drug therapy of ischemic heart disease patients with stable angina and stenosing atherosclerosis of the coronary arteries].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Angina Pectoris; Calcium Channel Blockers; Cardiac G | 1987 |